AutoGenomics' Automated Multiplexing Molecular Diagnostic Platform Available In Israel Through Medison Pharma Ltd.
The Medison Group has signed an agreement with Autogenomics for exclusive representation of its INFINITI™ system in Israel. This is one of the first automated microarray-based multiplexing molecular diagnostic platforms available on the market.
INFINITI can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious diseases, cancer and pharmacogenetics. With discovery of genes and their link to various disease states, this system has the versatility to revolutionize the way patients are diagnosed, monitored and managed, leading to the new era of personalized medicine.
For Meir Jakobsohn, President of Medison Group, this development is highly significant: “Through its ability to provide automated molecular genetics diagnostics, the INFINITI system heralds a new era in advanced technology offered to the healthcare authorities. and a breakthrough in the field of automated molecular genetics diagnostics which provides in advanced technology offered to the healthcare authorities. AutoGenomics’ breakthrough simplifies the process of molecular diagnostics, leading to vast saving in time and human resources.
In addition, the INFINITI™ system greatly improves the ability of laboratories to offer accurate, fast and advanced molecular diagnostics service in the fields of Genetics, Oncology, Infectious Disease and Pharmacogenomics".
AutoGenomics
AutoGenomics, Inc., a privately held company based in Carlsbad, CA, creates automation and technologies that simplify the complex test processes inherent in genomic and proteomic analysis. Its multiplexing diagnostic platforms empower clinical laboratories with an automated solution that significantly enhances work flow, cost efficiency, quicker turn-around time and results with enhanced patient care.
For more information: www.autogenomics.com
Medison Pharma
Medison Pharma is a leading Israeli marketing group focused in the fields of high quality pharmaceutical, medical devices and diagnostics products. With over a decade of experience, Medison is uniquely placed to provide a complete A to Z spectrum of integrated services for international companies looking to enter or expand their presence in the Israeli healthcare market, as well as in Romania and Slovakia.
Contact: Medison Pharma Ltd, Israel Tel: + 972-3-9250250 Email: medison@medison.co.il Site: www.medisonpharma.com
INFINITI can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious diseases, cancer and pharmacogenetics. With discovery of genes and their link to various disease states, this system has the versatility to revolutionize the way patients are diagnosed, monitored and managed, leading to the new era of personalized medicine.
For Meir Jakobsohn, President of Medison Group, this development is highly significant: “Through its ability to provide automated molecular genetics diagnostics, the INFINITI system heralds a new era in advanced technology offered to the healthcare authorities. and a breakthrough in the field of automated molecular genetics diagnostics which provides in advanced technology offered to the healthcare authorities. AutoGenomics’ breakthrough simplifies the process of molecular diagnostics, leading to vast saving in time and human resources.
In addition, the INFINITI™ system greatly improves the ability of laboratories to offer accurate, fast and advanced molecular diagnostics service in the fields of Genetics, Oncology, Infectious Disease and Pharmacogenomics".
AutoGenomics
AutoGenomics, Inc., a privately held company based in Carlsbad, CA, creates automation and technologies that simplify the complex test processes inherent in genomic and proteomic analysis. Its multiplexing diagnostic platforms empower clinical laboratories with an automated solution that significantly enhances work flow, cost efficiency, quicker turn-around time and results with enhanced patient care.
For more information: www.autogenomics.com
Medison Pharma
Medison Pharma is a leading Israeli marketing group focused in the fields of high quality pharmaceutical, medical devices and diagnostics products. With over a decade of experience, Medison is uniquely placed to provide a complete A to Z spectrum of integrated services for international companies looking to enter or expand their presence in the Israeli healthcare market, as well as in Romania and Slovakia.
Contact: Medison Pharma Ltd, Israel Tel: + 972-3-9250250 Email: medison@medison.co.il Site: www.medisonpharma.com